The finalists for the 2026 CPHI Pharma Awards span15 categories including API development, digital transformation, manufacturing, supply chain, sustainability, and leadership, with winners revealed ...

In part 1 of this 2-part preview of AAPS PharmSci 360’s keynote on predictive drug development, Robert Holt, PhD, associate director, Pharmaceutical Science, digiM Solution, explains microstructure ...

In August 2026, Heidi Overton was nominated for FDA commission, and a wave of oncology and neuro drugs were approved. In August 2026, a new FDA commissioner was nominated by the White House; there was ...

On August 31, 2026, Eli Lilly announced it has entered a definitive agreement to acquire Merida Biosciences, a biotechnology ...

The FDA cleared four notable therapies within the same week in late August, spanning infectious disease, cardiometabolic care ...

David S. Thompson, CSAP, is Chief Alliance Officer at Eli Lilly and Company.

Marco Anelli, MD | Authors | Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.

In December 2025, FDA announced that it was deploying agentic AI capabilities across the agency. FDA defined these systems as ...

This article explores strategies for formulating complex and emerging biologics, the role of predictive modeling, and ...

FDA approves Rasonque (daraxonrasib), the first broad RAS-targeted therapy for metastatic pancreatic cancer, validating RAS ...

Continuous direct compression can provide a simplified alternative pathway for selected spray-dried dispersion formulations ...

On August 19,2026, the FDA accepted Teva Pharmaceuticals' New Drug Application (NDA) for ecopipam, an investigational ...